GT Biopharma, Inc. (GTBP) - Dana dhuwit diétung saben saham

Lambang korporat lan logo GT Biopharma Corporation (GTBP)

GT Biopharma, Inc. (GTBP) is implementing eco-friendly laboratory cycles for reagent disposal, which confirms the cash per share listed on GURU.Markets, where the metric is fixed at 4.68. This trend reflects a total capital burn due to the absence of commercial products, as well as the early-stage testing of immuno-oncology drugs, creating a period of laboratory anticipation without profit generation.

GTBP gtbiopharma.com: Dana dhuwit saben saham ing interval 04.07.2022 - 20.11.2026

Rincian metrik komprehensif lan analitis gtbiopharma.com (GTBP)

- rincian posisi dhuwit lan arus kas:
Analisis komprehensif perusahaan:GT Biopharma Corporation - GTBP
Barang unggulan GT Biopharma, Inc.

GT Biopharma, Inc. (GTBP) is actively developing its innovative TriKE platform to combat hematological diseases. An analysis of the cash per share structure determines the volume of net liquidity attributable to a single security. This metric measures financial stability, allowing for an assessment of the balance between capital security and the pace of expansion. The stable trajectory of this chart confirms market confidence in the brand's scientific potential. A high cash reserve guarantees protection against bankruptcy, supporting the fundamental strength of the price.